Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DHX30 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | RP11-159D12.5 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | HPF1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | CUEDC1 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | KATNA1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | LMNA | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | C4orf46 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | WDR82 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | SCAF4 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |